FDA Investigator Jodi M Gatica
Jodi M Gatica has conducted inspections on 83 sites in 1 countries as of 04 Feb 2013. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
83
Last Inspection Date:
04 Feb 2013
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jodi M Gatica:
Abby Lmozeke Baker,
Adam C Hipko,
Adrian Rodriguez,
Akbar J Zaidi,
Albert F Peacock, PhD,
Alcee M Tavarez,
Amanda J White,
Andrea A Branche,
Anh M Lac,
Anitha Palamakula Govada,
Anya Dlockett Evans,
Aqualia L Nelson,
Arie R Dyk,
Ariel Cruz Figueroa,
Ashley N Williams,
Astrid M Rylander,
Becky L Bhan,
Betsy C Galliher,
Bing Lin,
Blondell W Johnson,
Bobbi J Miller,
Brackens Harris,
Brandon K Barbee,
Brian Sanders,
Carlos Chavez,
Carol A Declouette Wilburn,
Carol Rivera Lopez, PhD,
Casey L Hamblin,
Cathleen A Castellaw,
Chad J Whitwell,
Charles B Steinmiller,
Charles D Brown,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher K Gibbs,
Christopher L Jacobs,
Connie L Hannon Rabel,
Constance M Dobbins,
Crystal S Harris,
Cymbre Weatherly,
Cynthia A Harris, MD, RN,
Dallas E Gilbreath Jr,
Dana M Lewis,
Daniel J Lahar,
Daniel S Fam,
Danielle Lyke,
Danny D Horner,
Darla J Christopher,
David M Beltran,
Dawn P Hall,
Decarlos A Gomez,
Denise Connelly,
Deniza Karacic,
Diana L Ayala,
Dirk L Lincoln,
Dr. Jason R Caballero,
Dr. Sriram Subramaniam, PhD,
Edward D Edmiston,
Elisa M Fleming,
Elizabeth D Connell,
Ellen J Tave,
Elmina E Akwo,
Elmina E Mboh,
Emilio O Escobar,
Erick G Marchan,
Erma Zaimova,
Ernest Serna, III,
Fernando C Martinez,
Florecia S Philogene,
Frans E Mercado,
Gatica,
Grant L Davis,
Gretchen M Laws,
H Ljamilla Selby,
Hala L Selby,
Hugh M Mcclure, II,
Hung V Le,
J Elkins,
Jacob W Reynolds,
Jacqueline A O'shaughnessy, PhD,
Jake T Lane,
Jamie M Bumpas,
Jd Young,
Jeffrey R Wooley,
Jennifer D Young,
Jennifer Hua,
Jennifer O Dowdy,
Jeremy L Stukes,
Jessica M Simpson, PhD,
Joel D Martinez,
Johann M Fitch,
John A Kadavil, PhD,
Johnson,
Jonaida Estevez Martinez,
Jonathan A Womack,
Jonathan M Mcbride,
Jose Martinez, Jr,
Joshua L Gibbs,
Jude C Dikes,
Karen C Daugherty,
Kari M Johansen,
Kari M Laynor,
Karlton T Watson,
Kathleen B Swat,
Kathleen Chmura Shaffer,
Kayla R Deatherage,
Kenitra D Hewitt,
Kevin T Nguyen,
Kip J Hanks,
Kunapuli T Madhusudhan,
L Grant,
Latorie S Jones,
Lauren E Skokan,
Leighton Kn Gai,
Lillie M Young,
Lisa M Puttonen,
Lisa R Jennings,
Lisa R Whitt,
Liza L Quiles,
Loan T Tran,
Lorie S Hannappel,
Lourdes R Genera,
Lucas B Leake,
Maira P Brading,
Marc A Jackson, Jr,
Marc R Dickens,
Margaret M Annes,
Margarito J Uribe,
Mariana F Baxter,
Martha S Baldwin,
Martin K Yau, PhD,
Massoud Motamed,
Matthew J Gretkierewicz,
Matthew R Maddox,
Michael L Jones,
Michelle A Krayer,
Michelle Paxon,
Monique Rac Lester,
Nimmy Mathews,
Ninfa N Innocent,
Olalere D Fasipe,
Patrice S Hall,
Patrick D Stone, MS,
Patty P Kaewussdangkul,
Paul E Frazier,
Pauline N Logan,
Payne,
Philip M Steele, PhD,
Phillip D Waldron,
Phillip J Sample,
Qing Delgado,
Quynh Anh H Tran,
Rendall E Barfoot,
Rian L Pope,
Robert Barron,
Robert D Tollefsen,
Robert M Tillman,
Ronda Rloyd Jones,
Saijal P Naik,
Sam H Haidar, PhD,
Sandy J Ziegler,
Scott T Ballard,
Sean C Johnson,
Seri L Essary,
Sha'tina R Alridge,
Shanna N Purdy,
Shannon A Lowe,
Shawn E Larson,
Shelby N Turner,
Sherrie L Krolczyk,
Sonia R Peterson,
Staci G Mcallister,
Stephen D Brown,
Stephen L Beekman,
Steven A Gonzales,
Tamera H Hunt,
Tara A Gray,
Terri E Gibson,
Timothy H Vo,
Toby Vern H Hill,
Torrance J Slayton,
Tracy J Washington,
Travis M Beard,
Travis S Brown,
Tricia S Martinez,
Tricia Y Samaniego,
Trina K Vick,
Uttaniti Limchumroon (Tom),
Vilmary Negron Rodriguez,
Vitaliy N Guyvan,
William F Lagud, Jr,
Xikui Chen (nmi), PhD,
Yasamin Ameri,
Yaw O Osei,
Young M Yoon,
Yumi J Hiramine
Jodi M Gatica's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2012 | FDA 483 | Texas Applied Biotechnology Research Review Committee - Form 483, 2012-04-25 |
May, 2010 | FDA 483 | Dixie Chemical Co, Inc - Form 483, 2010-05-21 |
August, 2009 | FDA 483 | Morton Salt, Inc. - Form 483, 2009-08-06 |
August, 2012 | FDA 483 | United Laboratories Manufacturing, LLC - Form 483, 2012-07-30 |
January, 2011 | FDA 483 | Reckitt Benckiser, Inc. - Form 483, 2011-01-05 |
August, 2012 | EIR | United Laboratories Manufacturing, LLC - EIR, 2012-08-16 |
October, 2011 | FDA 483 | Muzaffar H. Qazilbash, M.D. - Form 483, 2011-10-14 |
March, 2010 | FDA 483 Response | Mission Pharmacal Company - Form 483R, 2010-03-25 |
March, 2010 | EIR | Mission Pharmacal Company - EIR, 2010-03-12 |
December, 2012 | FDA 483 | Ampharmco, LLC - Form 483, 2012-12-12 |
April, 2012 | EIR | Texas Applied Biotechnology Research Review Committee - EIR, 2012-04-25 |
July, 2010 | FDA 483 | United Pet Group, Inc. - Form 483, 2010-07-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more